Search research articles
Contact Us
Filters
Showing results (241-250 of 293) with videos related to
Page
of 30
Sort By:
Cancer Immunology Research
|
May 28, 2015
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation
Eliezer M Van Allen, Hadrien G Golay, Yan Liu, et al.
Nature Medicine
|
December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance
Akinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.
Nature Immunology
|
October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockade
Brian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Communications
|
February 18, 2016
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama, Esra A Akbay, Yvonne Y Li, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Oncoimmunology
|
June 15, 2018
TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor <i>CD274</i> (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas
Tsuyoshi Hamada, Thing Rinda Soong, Yohei Masugi, et al.
Immunity
|
April 21, 2022
Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironments
Sizun Jiang, Chi Ngai Chan, Xavier Rovira-Clavé, et al.
Nature Genetics
|
August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao, Claire A Margolis, Natalie I Vokes, et al.
Blood
|
September 2, 2020
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
Gabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, et al.
Blood
|
December 25, 2015
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 293) with videos related to
Sort By:
Page
of 30
Cancer Immunology Research
|
May 28, 2015
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation
Eliezer M Van Allen, Hadrien G Golay, Yan Liu, et al.
Nature Medicine
|
December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance
Akinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.
Nature Immunology
|
October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockade
Brian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Communications
|
February 18, 2016
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama, Esra A Akbay, Yvonne Y Li, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Oncoimmunology
|
June 15, 2018
TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor <i>CD274</i> (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas
Tsuyoshi Hamada, Thing Rinda Soong, Yohei Masugi, et al.
Immunity
|
April 21, 2022
Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironments
Sizun Jiang, Chi Ngai Chan, Xavier Rovira-Clavé, et al.
Nature Genetics
|
August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao, Claire A Margolis, Natalie I Vokes, et al.
Blood
|
September 2, 2020
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
Gabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, et al.
Blood
|
December 25, 2015
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, et al.
Page
of 30